Skip to main content
Gujarat Themis Biosyn Ltd. logo

Gujarat Themis Biosyn Ltd. — Investor Relations & Filings

Ticker · GUJTHEM ISIN · INE942C01045 LEI · 3358009IT99XRO254Q79 BSE.NS Manufacturing
Open in API
Filings indexed 696 across all filing types
Latest filing 2025-11-03 Regulatory Filings
Country IN India
Listing BSE.NS GUJTHEM

About Gujarat Themis Biosyn Ltd.

https://www.gtbl.in

Gujarat Themis Biosyn Ltd. specializes in the manufacture of active pharmaceutical ingredients and intermediates through advanced fermentation technology. The company focuses on the production of fermentation-based bulk drugs, with a primary product portfolio that includes Rifampicin intermediates and Lovastatin. Utilizing large-scale fermentation processes, the organization engages in strain improvement and media optimization to enhance yield and efficiency. The company operates a dedicated manufacturing facility equipped for complex biotechnological processes. Through technical collaborations with international entities, it has integrated specialized expertise in fermentation science to support the development of high-purity chemical compounds. Its operations are centered on providing essential building blocks for various therapeutic applications, maintaining a focus on technical precision and process-driven manufacturing excellence.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-03 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the date of a forthcoming Board meeting to consider and approve unaudited financial results for the quarter and half year ended 30th September 2025. It references compliance with SEBI regulations and insider trading window closure. The document does not contain any financial data or results itself, nor does it include the actual financial report. It is an announcement of a Board meeting date and related procedural information. The document length is only 2198 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to exchanges, not a financial report or detailed management information.
2025-11-03 English
Capacity addition
Capital/Financing Update Classification · 95% confidence The document is a short announcement (2190 characters) addressed to stock exchanges regarding the commencement of commercial production at a new fermentation plant. It references compliance with SEBI Listing Obligations and Disclosure Requirements, specifically Regulation 30, which pertains to material event disclosures. The content is an update on operational capacity expansion and does not contain financial statements, detailed financial data, or management analysis. It is not a full report but an informational notice about a corporate event. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to capacity expansion and operational growth, which impacts the company's capital assets and production capabilities.
2025-10-18 English
Please refer to attached file
Regulatory Filings Classification · 95% confidence The document is a formal communication from Gujarat Themis Biosyn Limited to stock exchanges (BSE and NSE) regarding the commencement of commercial production at a new fermentation plant. It references compliance with SEBI Listing Obligations and Disclosure Requirements (Regulation 30), which pertains to disclosure of material events. The content is an announcement about operational expansion and capacity increase, not a financial report or detailed analysis. The document length is short (2190 characters), and it serves as an informational notice rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-10-18 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a newspaper publication notice about a special window for re-lodgement of transfer requests of physical shares. It references a SEBI circular and includes newspaper clipping attachments. The content is primarily an announcement of a notice published in newspapers and available on the company's website. There are no financial statements, management discussion, or detailed financial data. The document length is about 15,000 characters but the content is an announcement of a notice, not the notice or report itself. Therefore, it fits the category of Report Publication Announcement (RPA) rather than a full report or regulatory filing.
2025-10-16 English
please refer to the attachment.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a newspaper publication notice about a special window for re-lodgement of transfer requests of physical shares. It references a SEBI circular and includes details about the publication in newspapers and availability on the company's website. The content is primarily an announcement of a notice publication rather than a detailed report or financial statement. The document length is about 15,000 characters but the content is an announcement of a notice publication, not the report itself. Therefore, according to the 'Menu vs Meal' rule, this should be classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit into other specific categories like Annual Report, Interim Report, or Capital Update.
2025-10-16 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.